Your browser doesn't support javascript.
loading
DDX41 is required for cGAS-STING activation against DNA virus infection.
Singh, Ravi Shankar; Vidhyasagar, Venkatasubramanian; Yang, Shizhuo; Arna, Ananna Bhadra; Yadav, Manisha; Aggarwal, Aanchal; Aguilera, Alexya N; Shinriki, Satoru; Bhanumathy, Kalpana Kalyanasundaram; Pandey, Kannupriya; Xu, Aizhang; Rapin, Noreen; Bosch, Mark; DeCoteau, John; Xiang, Jim; Vizeacoumar, Franco J; Zhou, Yan; Misra, Vikram; Matsui, Hirotaka; Ross, Susan R; Wu, Yuliang.
Afiliación
  • Singh RS; Department of Biochemistry, Microbiology and Immunology, University of Saskatchewan, Saskatoon SK S7N 5E5, Canada.
  • Vidhyasagar V; Department of Biochemistry, Microbiology and Immunology, University of Saskatchewan, Saskatoon SK S7N 5E5, Canada.
  • Yang S; Department of Biochemistry, Microbiology and Immunology, University of Saskatchewan, Saskatoon SK S7N 5E5, Canada.
  • Arna AB; Department of Biochemistry, Microbiology and Immunology, University of Saskatchewan, Saskatoon SK S7N 5E5, Canada.
  • Yadav M; Department of Biochemistry, Microbiology and Immunology, University of Saskatchewan, Saskatoon SK S7N 5E5, Canada.
  • Aggarwal A; Department of Biochemistry, Microbiology and Immunology, University of Saskatchewan, Saskatoon SK S7N 5E5, Canada.
  • Aguilera AN; Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
  • Shinriki S; Department of Molecular Laboratory Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
  • Bhanumathy KK; Saskatchewan Cancer Agency, Saskatoon, SK S7N 5E5, Canada.
  • Pandey K; Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac), University of Saskatchewan, Saskatoon, SK S7N 5E3, Canada.
  • Xu A; Saskatchewan Cancer Agency, Saskatoon, SK S7N 5E5, Canada.
  • Rapin N; Department of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK S7N 5B4, Canada.
  • Bosch M; Saskatchewan Cancer Agency, Saskatoon, SK S7N 5E5, Canada.
  • DeCoteau J; Department of Pathology and Laboratory Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
  • Xiang J; Saskatchewan Cancer Agency, Saskatoon, SK S7N 5E5, Canada.
  • Vizeacoumar FJ; Saskatchewan Cancer Agency, Saskatoon, SK S7N 5E5, Canada; Department of Pathology and Laboratory Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
  • Zhou Y; Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac), University of Saskatchewan, Saskatoon, SK S7N 5E3, Canada; Department of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK S7N 5B4, Canada.
  • Misra V; Department of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK S7N 5B4, Canada.
  • Matsui H; Department of Molecular Laboratory Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
  • Ross SR; Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
  • Wu Y; Department of Biochemistry, Microbiology and Immunology, University of Saskatchewan, Saskatoon SK S7N 5E5, Canada. Electronic address: yuliang.wu@usask.ca.
Cell Rep ; 39(8): 110856, 2022 05 24.
Article en En | MEDLINE | ID: mdl-35613581

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Interferón Tipo I / Infecciones por Virus ADN Límite: Humans Idioma: En Revista: Cell Rep Año: 2022 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Interferón Tipo I / Infecciones por Virus ADN Límite: Humans Idioma: En Revista: Cell Rep Año: 2022 Tipo del documento: Article País de afiliación: Canadá